Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
New hope for advanced stomach cancer: experimental combo targets HER2
Disease control OngoingThis study tests whether a new drug called zanidatamab, given with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for people with advanced HER2-positive stomach or esophageal cancer that has spread or cannot be removed by …
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Epidiolex liver check: no alarm, just monitoring
Knowledge-focused OngoingThis study watches for possible long-term liver damage in 154 people already taking or starting Epidiolex for certain seizure disorders. Researchers will use blood tests and special scans to check for liver scarring over time. The goal is to understand if the drug can cause chron…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC